Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model

Figure 3 Histological changes of liver samples. A: Control group: treated with vehicle only; B: Morin group: treated with morin at a dose of 50 mg/kg twice a week; C: CCl₄ group: injected with CCl₄ at a dose of 2 mL/kg twice a week; D: Morin + CCl₄ group: treated with the same volume of morin and CCl₄ as the morin and CCl₄ groups. Liver tissues were stained with H&E (× 100).